Arinjay Sarma
About Arinjay Sarma
Arinjay Sarma is a Market Analyst specializing in cell and gene therapy trends, currently working at Virica Biotech in Toronto. He has a background in biotechnology and molecular genetics, with previous experience at Bureau Veritas Group and the University of Guelph.
Current Role at Virica Biotech
Arinjay Sarma currently serves as a Market Analyst at Virica Biotech, a position he has held since 2023. In this role, he conducts extensive research on the viral vector manufacturing sector, focusing on identifying challenges and opportunities within the industry. He is part of an agile Business Development Team that generates marketing collateral specifically for the cell and gene therapy sector. Additionally, he engages with industry professionals to enhance viral vector yield and quality through strategic connections.
Previous Experience at Virica Biotech
Prior to his current position, Arinjay Sarma worked at Virica Biotech as a Market Analyst for a duration of 7 months in 2022. During this time, he contributed to the company's understanding of market trends and developments in the cell and gene therapy field. His insights played a role in shaping the company's strategic direction and marketing efforts.
Experience at Bureau Veritas Group
Arinjay Sarma was employed at Bureau Veritas Group as Project Submissions Support from 2019 to 2020 for one year in Edmonton, Alberta, Canada. In this role, he supported project submissions, contributing to the operational efficiency of the organization. His experience at Bureau Veritas Group provided him with valuable insights into project management and support processes.
Educational Background in Biotechnology
Arinjay Sarma achieved a Master's degree in Biotechnology from the University of Guelph, where he studied from 2021 to 2022. His academic background provided him with a strong foundation in the principles of biotechnology, which he applies in his current role. Additionally, he holds a Bachelor's degree in Molecular Genetics from the University of Alberta, where he studied from 2014 to 2018.
Contributions to Industry Publications
Arinjay Sarma actively contributes to industry publications, including writing for Virica's Industry Insights editions. He has published articles in the April and January 2024 editions, sharing curated insights on cell and gene therapy trends and developments. His contributions help inform and engage professionals in the biotechnology sector.